Extracting tangible value from AI in Regulatory Affairs, Compliance & More
In anticipation of a rousing Breakthrough 2025, Regulatory consultant and panel session moderator Preeya Beczek sets out her hopes for this year’s event.

Madrid, Spain
10 – 11 Feb 2026
Operationalizing AI: Turning proven AI use cases into everyday practice across life sciences.

SVP, Head of Regulatory Affairs and PV Operations
Astellas


SVP, Worldwide Patient Safety Officer
Bristol Myers Squibb

In anticipation of a rousing Breakthrough 2025, Regulatory consultant and panel session moderator Preeya Beczek sets out her hopes for this year’s event.
Steve Gens previews some of the new research findings he’ll come armed with to a discussion panel on the future of Regulatory operations in an AI automation context.Â
Breakthrough 2025 is set to be a pivotal event for safety, regulatory, and life sciences professionals.
In the rapidly evolving landscape of regulatory affairs, significant advancements and trends are shaping the future. At ArisGlobal, we're committed to staying at the forefront of these changes and ensuring our clients are well-prepared. Here's a deep dive into the latest developments and what to expect in the coming years.Â
Learn how new advancements in artificial intelligence (AI) and generative AI (GenAI) are transforming Agency queries and information exchanges.
Learn how new advancements in artificial intelligence (AI) and generative AI (GenAI) are transforming Agency queries and information exchanges.
Learn how new advancements in artificial intelligence (AI) and generative AI (GenAI) are transforming Agency queries and information exchanges.
In the ever-evolving pharmacovigilance landscape , embracing automation and AI has become a strategic necessity for global pharmaceutical companies.
A reported 86% of pharmaceutical companies plan to significantly increase their investment in automation technologies over the next five years.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempora.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved